Malabsorption News

Children with both celiac disease and type 1 diabetes had a lower height standard deviation score than children with type 1 diabetes alone, according to findings published in Diabetes Care.

The Celiac Disease Foundation and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition have collaborated to develop the NASPGHAN Clinical Guide for Pediatric Celiac Disease, a decision tree tool to help clinicians diagnose and manage children with celiac disease, according to a press release.

Nexvax2, an investigational therapeutic vaccine designed to protect patients with celiac disease against the effects of gluten exposure, was safe and well tolerated, and demonstrated a modified immune response to gluten in two phase 1 randomized controlled trials.

Gluten-free products have significantly different nutritional composition than their counterparts that contain gluten, which could especially impact children with celiac disease, according to research presented at the European Society for Pediatric Gastroenterology, Hepatology and Nutrition annual meeting.

CHICAGO — At the AGA Presidential Plenary at Digestive Disease Week, newly appointed AGA President Sheila Crowe, MD, from University of California, San Diego, highlighted the latest developments in celiac disease and wheat sensitivity disorders.

Researchers found that long-term consumption of gluten was not associated with coronary heart disease risk, and recommended against a gluten-free diet for people without celiac disease as it could limit their intake of “heart-healthy” whole grains.

Adding oats to increase the nutritional value of a gluten-free diet does not appear to affect symptoms, histology, immunity or serologic features of patients with celiac disease, according to new research published in Gastroenterology.

An asymptomatic infection with a common but innocuous reovirus can trigger the immune system’s inflammatory response to gluten and lead to the development of celiac disease, according to new study results.

The FDA authorized marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 diseases and conditions, including Alzheimer’s disease, Parkinson’s disease and celiac disease.

Researchers found a positive association between anorexia nervosa and celiac disease, both before and after celiac diagnosis, in a Swedish nationwide study.